---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-002001"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2025-03-24T23:59:59+00:00"
generated_at: "2026-05-24T06:20:24.521135+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cyclacel raises $1M via Series E convertible preferred stock; extends cash runway to Q3 2025

## Summary
- Gross proceeds of $1.0M from sale of 1M shares of Series E Convertible Preferred Stock at $1.00 per share.
- Each Series E share convertible into 110 common shares, subject to stockholder approval per Nasdaq rules.
- Offering closed on March 21, 2025; net proceeds for working capital and general corporate purposes.
- Cash runway extended into third quarter 2025 based on current operating assumptions.
- Securities sold under Regulation S exemption, no placement agent used.

## SEC filing metadata
- accession: 0001829126-25-002001
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2025-03-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 1.01, 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000182912625002001/0001829126-25-002001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000182912625002001/cyclacel_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-002001
- JSON: https://secwatch.observer/filing/0001829126-25-002001.json
- Plain text: https://secwatch.observer/filing/0001829126-25-002001.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.